Inventor
KENNISTON JON A
US11 patents
⚠️ This page may combine multiple inventors who share the name “KENNISTON JON A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
10 patentsUS11084884B2Aug 10, 2021
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
TAKEDA PHARMACEUTICALS CO23 citations91
US11372002B2Jun 28, 2022
Assays for determining plasma kallikrein system biomarkers
TAKEDA PHARMACEUTICALS CO9 citations84
US11299553B2Apr 12, 2022
Anti-plasma kallikrein antibodies
TAKEDA PHARMACEUTICALS CO8 citations83
US12110343B2Oct 8, 2024
Anti-plasma kallikrein antibodies
TAKEDA PHARMACEUTICALS CO4 citations72
US11156612B2Oct 26, 2021
Methods of determining levels of cleaved and/or intact kininogen
TAKEDA PHARMACEUTICALS CO6 citations71
US11390687B2Jul 19, 2022
Bispecific antibodies against plasma kallikrein and Factor XII
TAKEDA PHARMACEUTICALS CO3 citations67
US12442824B2Oct 14, 2025
Assays for determining plasma kallikrein system biomarkers
TAKEDA PHARMACEUTICALS CO0 citations61
US12384854B2Aug 12, 2025
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
TAKEDA PHARMACEUTICALS CO1 citations61
US12415866B2Sep 16, 2025
Monoclonal antibody inhibitor of Factor XIIa
TAKEDA PHARMACEUTICALS CO0 citations60
US12240918B2Mar 4, 2025
Bispecific antibodies against plasma kallikrein and factor XII
TAKEDA PHARMACEUTICALS CO0 citations56